7.2.3 Customer 7.2.3 Communication — New requirement related to communication with regulatory “The organization shall
communication authorities. communicate with regulatory
authorities in accordance with
applicable regulatory
ISO 13485:2003, ISO 13485:2016, EN Comments on change from ISO doc itself – Table A1 Personal interpretation /details /
EN ISO ISO 13485:2016 extracts
13485:2012
requirements.” Weird statement
placement
7.3 Design and 7.3 Design and - Added requirements to list. 7.3.2 e) the methods to ensure
development development — Eliminated the requirement related to the management of the traceability of design and
7.3.1 Design and 7.3.1 General interfaces between different groups involved in design and development outputs to design
development 7.3.2 Design and development. and
planning development development inputs;
planning - f) the resources needed,
including necessary competence
of personnel.
7.3.2 Design and 7.3.3 Design and — Added requirements to list. - Added “usability” + ref to
development development inputs — Added requirement that the requirements shall be able to be IEC62366
inputs verified or validated.
7.3.3 Design and 7.3.4 Design and No Change - No Change
development development outputs
outputs
7.3.4 Design and 7.3.5 Design and Added details of the contents of records. “include the
development development review - identification of the design
review under review, the participants
involved and the date of the
review”
7.3.5 Design and 7.3.6 Design and Added requirement for documentation of verification plans and New : “The organization shall
development development interface considerations. document verification plans that
verification verification — Requirement added for records of verification. include methods, acceptance
criteria and, as
appropriate, statistical
techniques with rationale for
sample size.
If the intended use requires that
the medical device be connected
to, or have an interface with,
other
medical device(s), verification
shall include confirmation that
the design outputs meet design
inputs
ISO 13485:2003, ISO 13485:2016, EN Comments on change from ISO doc itself – Table A1 Personal interpretation /details /
EN ISO ISO 13485:2016 extracts
13485:2012
- when so connected or
interfaced.”
Also added “Records of the
- results AND CONCLUSIONS
of […]”
7.3.6 Design and 7.3.7 Design and — Added requirement for documentation of validation plans, product to New “The organization shall
development development be used for validation document validation plans that
validation validation and interface considerations. Requirement added for records of include methods, acceptance
validation. criteria and, as appropriate,
statistical techniques with
rationale for sample size.” New
“A medical device used for
clinical evaluation or
performance evaluation is not
considered to be released for use
to the customer. If the intended
use requires that the medical
device be connected to, or have
an interface with, other medical
device(s), validation shall include
confirmation that the
requirements for the specified
application or intended use have
been met when so connected or
interfaced”
7.3.8 Design transfer New Sub-clause added A medical device used for clinical
evaluation or performance
evaluation is not considered to
be released for use to the
customer. If the intended use
requires that the medical device
be connected to, or have an
interface with, other medical
device(s), validation shall include
confirmation that the
requirements for the specified
ISO 13485:2003, ISO 13485:2016, EN Comments on change from ISO doc itself – Table A1 Personal interpretation /details /
EN ISO ISO 13485:2016 extracts
13485:2012
- application or intended use
have been met when so
connected or interfaced
7.3.7 Control of 7.3.9 Control of Adds the requirement that the evaluation of the change effect should be New “:The organization shall
design and design and made on products in process and on the outputs of risk management and determine the significance of the
development development changes product realization processes change to function, performance,
changes — Added detail to consider in the determination of the significance of a usability, safety and applicable
design and development changes regulatory requirements for the
medical device and its intended
use.”
- Also note the “products in process
and on the outputs of risk
management and product
realization processes” as opposed
to only released products +
records of “changes, THEIR
REVIEW […]”
7.3.10 Design and — New sub-clause added. - New but not really – i.e. DHF
development files
7.4 Purchasing 7.4 Purchasing — Focuses the supplier selection criteria on the effect of the supplier - As explained
7.4.1 Purchasing 7.4.1 Purchasing performance on the quality of the medical device, the risk associated
process process with the medical device, and the product meeting applicable regulatory
requirements.
— New requirements added related to monitoring and re-evaluation of
suppliers, and action to be taken when purchasing requirements are not
met.
— Provides addition details related to the content of the records.
7.4.2 Purchasing 7.4.2 Purchasing — New requirement added to include notification of changes in “Purchasing information shall
information information purchased product. include, as applicable, a written
agreement that the supplier
notify the organization of
changes in the purchased
product prior to implementation
of any changes that affect
- the ability of the purchased
product to meet specified
purchase requirements”
ISO 13485:2003, ISO 13485:2016, EN Comments on change from ISO doc itself – Table A1 Personal interpretation /details /
EN ISO ISO 13485:2016 extracts
13485:2012
7.4.3 Verification 7.4.3 Verification of New requirements added on the extent of verification activities and Also new “The extent of
of purchased purchased product action to be taken when the organization becomes aware of any changes verification activities shall be
product to the purchased product. based on the supplier evaluation
results and proportionate to the
risks associated with the
purchased product. When the
organization becomes aware of
any changes to the purchased
product, the organization shall
determine whether these
changes affect the product
realization process or the
medical device.”
7.5 Production 7.5 Production and 7.5.1 - Adds details related to the controls for carrying out production - Rewording but can’t find anything
and service service provision and service provision. really different ?
provision 7.5.1 Control of
7.5.1 Control of production and
production and service provision
service provision
7.5.1.1 General
requirements
7.5.1.2 Control of 7.5.2 Cleanliness of 7.5.2 - Added a requirement to the list. - New c) product cannot be
production and product cleaned prior to sterilization or
service provision its use, and its cleanliness is of
- Specific significance in use;
requirements
7.5.1.2.1
Cleanliness of
product and
contamination
control
7.5.2 Validation 7.5.6 Validation of -Added requirements to the list - d) as appropriate, statistical
of processes for processes for — Adds details related to situations requiring procedures. techniques with rationale for
production and production and — Relates the specific approach to software validation to the risk sample sizes;
service provision service provision associated with the use of - f/criteria for revalidation;
7.5.2.1 General the software. - g) approval of changes to the
requirements — Adds requirements related to the validation records. processes.
The specific approach and
activities associated with
software validation and
revalidation shall be
proportionate to the risk
associated with the use of the
software, including the effect on
the ability of the product to
conform to specifications.